Q1 2026 earnings call recap: guidance raise, $15B revenue, Skyrizi/Rinvoq outlook, pipeline catalysts & risks—read key takeaways now.

BridgeBio Pharma, Inc. remains a Buy, driven by Attruby’s strong U.S. launch and favorable competitive dynamics. Learn more ...

Good afternoon. Welcome to the Penske Automotive Group First Quarter 2026 Earnings Conference Call. Today's call is being recorded and will be available for replay approximately 1 hour after ...

As a professional investor, I am proud to say that I have a good track record in the market. As an example, my largest ...

Fed holds rates at 3.50%-3.75% as dissent rises and inflation risks turn policy more hawkish. Click for a review of where ...

ServiceNow is executing strongly, delivering 22% YoY subscription revenue growth despite negative sentiment & AI disruption ...

Treasury Sec. Bessent blasts Jay Powell staying on Fed board, calls it a norms breach, as Kevin Warsh advances.

Meta Platforms, Inc. delivered robust Q1 results with 33% YoY revenue growth, strong ad momentum, and resilient user ...

Q1 2026 earnings call recap: 12% sales growth, data center-led C&I surge, $700M+ backlog, raised 2026 outlook & margin gains—read now.

Saccaro maintained the sales framework while lowering profit and cash expectations: “We’re maintaining our top line guidance of 3% to 4% organic sales growth,” and “we are prudently reducing our ...

Q1 2026. Management view "We delivered a strong quarter, reflecting both attractive underwriting margin and the disciplined ...

NXPI delivers a powerful Q1 beat with 12% revenue growth, signaling a major shift from stagnant trends. Click here to find ...